Back to results
CompletedPhase 3

A Study to Evaluate SAGE-217 in Adult Participants With Major Depressive Disorder (MDD)

NCT03864614

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Sage Investigational Site

Dothan, Alabama, United States

+51 additional locations

View on ClinicalTrials.gov
A Study to Evaluate SAGE-217 in Adult Participants With Major Depressive Disorder (MDD) — TrialFind